Ken Fisher's IBB Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 2,763 shares of iShares Biotechnology ETF (IBB) worth $466,314, representing 0.00% of the portfolio. First purchased in 2016-Q3, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in IBB, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2019, adding 11,072 shares. Largest reduction occurred in Q3 2019, reducing 8,681 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's iShares Biotechnology ETF (IBB) Holding Value Over Time
Track share changes against reported price movement
Quarterly iShares Biotechnology ETF (IBB) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +563 | Add 25.59% | 2,763 | $168.77 |
| Q3 2025 | -67 | Reduce 2.96% | 2,200 | $144.37 |
| Q2 2025 | -136 | Reduce 5.66% | 2,267 | $126.52 |
| Q1 2025 | -141 | Reduce 5.54% | 2,403 | $127.91 |
| Q4 2024 | +410 | Add 19.21% | 2,544 | $132.22 |
| Q3 2024 | -529 | Reduce 19.86% | 2,134 | $145.61 |
| Q2 2024 | -485 | Reduce 15.41% | 2,663 | $137.28 |
| Q1 2024 | +3,148 | New Buy | 3,148 | $137.25 |
| Q4 2023 | -1,691 | Sold Out | 0 | $0.00 |
| Q3 2023 | -331 | Reduce 16.37% | 1,691 | $122.32 |
| Q2 2023 | +199 | Add 10.92% | 2,022 | $126.99 |
| Q1 2023 | -5 | Reduce 0.27% | 1,823 | $129.17 |
| Q4 2022 | +1,828 | New Buy | 1,828 | $131.29 |
| Q3 2022 | -2,007 | Sold Out | 0 | $0.00 |
| Q2 2022 | -979 | Reduce 32.79% | 2,007 | $117.59 |
| Q1 2022 | +781 | Add 35.42% | 2,986 | $130.27 |
| Q4 2021 | +260 | Add 13.37% | 2,205 | $152.83 |
| Q3 2021 | -412 | Reduce 17.48% | 1,945 | $161.44 |
| Q2 2021 | +101 | Add 4.48% | 2,357 | $163.77 |
| Q1 2021 | -23 | Reduce 1.01% | 2,256 | $150.71 |
| Q4 2020 | +174 | Add 8.27% | 2,279 | $151.38 |
| Q3 2020 | +340 | Add 19.26% | 2,105 | $135.39 |
| Q2 2020 | -435 | Reduce 19.77% | 1,765 | $136.54 |
| Q1 2020 | -3,137 | Reduce 58.78% | 2,200 | $107.73 |
| Q4 2019 | +2,946 | Add 123.21% | 5,337 | $120.48 |
| Q3 2019 | -8,681 | Reduce 78.40% | 2,391 | $99.54 |
| Q2 2019 | +11,072 | New Buy | 11,072 | $109.10 |
| Q1 2019 | -7,659 | Sold Out | 0 | $0.00 |
| Q4 2018 | +5,772 | Add 305.88% | 7,659 | $96.49 |
| Q3 2018 | +1,887 | New Buy | 1,887 | $121.89 |
| Q2 2018 | -2,708 | Sold Out | 0 | $0.00 |
| Q1 2018 | -388 | Reduce 12.53% | 2,708 | $106.72 |
| Q4 2017 | +120 | Add 4.03% | 3,096 | $106.91 |
| Q3 2017 | +826 | Add 38.42% | 2,976 | $333.67 |
| Q2 2017 | +2,150 | New Buy | 2,150 | $310.23 |
| Q1 2017 | -808 | Sold Out | 0 | $0.00 |
| Q4 2016 | -609 | Reduce 42.98% | 808 | $264.85 |
| Q3 2016 | +1,417 | New Buy | 1,417 | $289.34 |
Ken Fisher's iShares Biotechnology ETF Investment FAQs
Ken Fisher first purchased iShares Biotechnology ETF (IBB) in Q3 2016, acquiring 1,417 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held iShares Biotechnology ETF (IBB) for 38 quarters since Q3 2016.
Ken Fisher's largest addition to iShares Biotechnology ETF (IBB) was in Q2 2019, adding 11,072 shares worth $1.21 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 2,763 shares of iShares Biotechnology ETF (IBB), valued at approximately $466,314.
As of the Q4 2025 filing, iShares Biotechnology ETF (IBB) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in iShares Biotechnology ETF (IBB) was 11,072 shares, as reported at the end of Q2 2019.